Farms.com Home   News

Acceligen successfully breeds gene-edited pigs with PRRS resistance

Acceligen, a leading innovator in sustainable agriculture, is proud to announce the breeding of gene-edited pigs with resistance to porcine reproductive and respiratory syndrome. This breakthrough represents a significant step forward in the pursuit for sustainable and ethical pork production.

PRRS is the most devastating disease to the swine industry in the United States, affecting not only the productivity of pigs, but also their health and wellness.  This regularly occurring and complex disease has been documented to cause an estimated $500 million USD of losses to the pork producers, thus affecting the food security of countless people around the world.

Click here to see more...

Trending Video

Pradalex: First New Injectable for Swine Respiratory Disease in 10+ Years | Dr. Pat Hoffman

Video: Pradalex: First New Injectable for Swine Respiratory Disease in 10+ Years | Dr. Pat Hoffman

At the 2025 World Pork Expo, Dr. Pat Hoffman discussed Pradalex — the first novel injectable antibiotic approved in over ten years. Developed to fight swine respiratory disease (SRD), Pradalex features a unique dual mode of action for stronger, more targeted treatment. In this interview, Dr. Hoffman shares how it works, its impact on SRD management, and why it marks a major milestone for swine health